Publikationen von Reinhard Hohlfeld

Zeitschriftenartikel (127)

2002
Zeitschriftenartikel
Wiendl, H.; Malotka, J.; Holzwarth, B.; Weltzien, H. U.; Wekerle, H.; Hohlfeld, R.; Dornmair, K.: An autoreactive gamma delta TCR derived from a polymyositis lesion. Journal of Immunology 169 (1), S. 515 - 521 (2002)
Zeitschriftenartikel
Meinl, E.; Hohlfeld, R.: Immunopathogenesis of multiple sclerosis: MBP and beyond. Clinical and Experimental Immunology 128 (3), S. 395 - 397 (2002)
Zeitschriftenartikel
Ziemssen, T.; Neuhaus, O.; Farina, C.; Hartung, H. P.; Hohlfeld, R.: Treatment of multiple sclerosis with glatiramer acetate - new information about its mechanisms of action, pharmacokinetics, adverse effects and clinical studies. Nervenarzt 73 (4), S. 321 - 331 (2002)
Zeitschriftenartikel
Farina, C.; Vargas-Leal, V.; Heydari, N.; Kümpfel, T.; Meinl, E.; Hohlfeld, R.: Treatment with glatiramer acetate induces specific IgG4 antibodies in multiple sclerosis patients. Journal of Neuroimmunology 123 (1-2), S. 188 - 192 (2002)
Zeitschriftenartikel
Stadelmann, C.; Kerschensteiner, M.; Misgeld, T.; Bruck, W.; Hohlfeld, R.; Lassmann, H.: BDNF and gp145trkB in multiple sclerosis brain lesions: Neuroprotective interactions between immune and neuronal cells? Brain 125, S. 75 - 85 (2002)
Zeitschriftenartikel
Wiendl, H.; Hohlfeld, R.: Therapeutic approaches in multiple sclerosis - Lessons from failed and interrupted treatment trials. Biodrugs 16 (3), S. 183 - 200 (2002)
Zeitschriftenartikel
Ziemssen, T.; Neuhaus, O.; Hohlfeld, R.: Risk-benefit assessment of glatiramer acetate in multiple sclerosis. Drug Safety 24 (13), S. 979 - 990 (2002)

Buchkapitel (1)

2008
Buchkapitel
Bradl, M.; Dornmair, K.; Hohlfeld, R.: New tools for investigating the immunopathogenesis of MS: Principles and applications. In: Multiple Sclerosis: A Comprehensive Text, S. 284 - 299 (Hg. S., R. C.; F., M. H.; R., H.). Saunders, Elsevier, Edinburgh (2008)

Meeting Abstract (3)

2015
Meeting Abstract
Hohlfeld, R.: Modulating microbiota: friend or foe? In MULTIPLE SCLEROSIS JOURNAL, 21, S. 53 - 53. 31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona, SPAIN, 07. Oktober 2015 - 10. Oktober 2015. SAGE PUBLICATIONS LTD, 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND (2015)
2012
Meeting Abstract
Beltran, E.; Obermeier, B.; Coret, F.; Simo-Castello, M.; Bosca, I.; Villar, L. M.; Wekerle, H.; Hohlfeld, R.; Dornmair, K.; Casanova, B.: Somatic hypermutation of intrathecal IgM-producing B cells in multiple sclerosis patients. In JOURNAL OF NEUROIMMUNOLOGY, 253 (1-2), S. 2 - 2. 11th International Congress of Neuroimmunology (ISNI), Boston, MA, 04. November 2012 - 08. November 2012. ELSEVIER SCIENCE BV, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS (2012)
2011
Meeting Abstract
Linington, C.; Arthur, A.; Mohan, H.; Elliott, C.; Krumbholz, M.; Barnett, S.; Wekerle, H.; Hohlfeld, R.; Lassmann, H.; Meinl, E.: THE ROLE OF FIBROBLAST GROWTH FACTOR-9 IN CHRONICALLY DEMYELINATED MULTIPLE SCLEROSIS LESIONS. In GLIA, 59 (Suppl. 1), S. S45 - S45. 10th European Meeting on Glial Cells in Health and Disease, Prague, CZECH REPUBLIC, 13. September 2011 - 17. September 2011. WILEY-BLACKWELL, COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA (2011)
Zur Redakteursansicht